Search research articles
Contact Us
Filters
Showing results (1221-1230 of 1,245) with videos related to
Page
of 125
Sort By:
Oncogene
|
November 15, 2000
Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma
N Iwata, H Yamamoto, S Sasaki, et al.
Alimentary Pharmacology & Therapeutics
|
October 17, 2017
Short-term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting anti-viral treatment
E Ogawa, N Furusyo, H Nomura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2016
Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003)
M Yamasaki, T Yasuda, M Yano, et al.
Cancer Gene Therapy
|
February 18, 2006
Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer
K Naruishi, T L Timme, N Kusaka, et al.
Diabetologia
|
May 24, 2013
Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse
G Kuriya, T Uchida, S Akazawa, et al.
Archives of Environmental Contamination and Toxicology
|
November 26, 2009
Enhanced inhibitory effects of TBT chloride on the development of F1 rats
H Asakawa, M Tsunoda, T Kaido, et al.
Molecular Therapy. Nucleic Acids
|
November 6, 2023
Local application of engineered insulin-like growth factor I mRNA demonstrates regenerative therapeutic potential <i>in vivo</i>
Justin S Antony, Pascale Birrer, Claudia Bohnert, et al.
Chemico-Biological Interactions
|
July 21, 2000
Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymes
S Narimatsu, N Kobayashi, Y Masubuchi, et al.
International Journal of Immunopathology and Pharmacology
|
April 10, 2010
Analysis on the co-localization of asbestos bodies and Fas or CD163 expression in asbestos lung tissue by in-air micro-pixe
S Matsuzaki, Y Shimizu, K Dobashi, et al.
British Journal of Cancer
|
February 20, 2008
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)
K Tamura, I Okamoto, T Kashii, et al.
Page
of 125
Search research articles
Search
Showing results (1221-1230 of 1,245) with videos related to
Sort By:
Page
of 125
Oncogene
|
November 15, 2000
Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma
N Iwata, H Yamamoto, S Sasaki, et al.
Alimentary Pharmacology & Therapeutics
|
October 17, 2017
Short-term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting anti-viral treatment
E Ogawa, N Furusyo, H Nomura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2016
Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003)
M Yamasaki, T Yasuda, M Yano, et al.
Cancer Gene Therapy
|
February 18, 2006
Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer
K Naruishi, T L Timme, N Kusaka, et al.
Diabetologia
|
May 24, 2013
Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse
G Kuriya, T Uchida, S Akazawa, et al.
Archives of Environmental Contamination and Toxicology
|
November 26, 2009
Enhanced inhibitory effects of TBT chloride on the development of F1 rats
H Asakawa, M Tsunoda, T Kaido, et al.
Molecular Therapy. Nucleic Acids
|
November 6, 2023
Local application of engineered insulin-like growth factor I mRNA demonstrates regenerative therapeutic potential <i>in vivo</i>
Justin S Antony, Pascale Birrer, Claudia Bohnert, et al.
Chemico-Biological Interactions
|
July 21, 2000
Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymes
S Narimatsu, N Kobayashi, Y Masubuchi, et al.
International Journal of Immunopathology and Pharmacology
|
April 10, 2010
Analysis on the co-localization of asbestos bodies and Fas or CD163 expression in asbestos lung tissue by in-air micro-pixe
S Matsuzaki, Y Shimizu, K Dobashi, et al.
British Journal of Cancer
|
February 20, 2008
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)
K Tamura, I Okamoto, T Kashii, et al.
Page
of 125